title: Developmental toxicity studies of caprolactam in the rat and rabbit.
abstract: Caprolactam was evaluated for developmental toxicity potential in both rats and rabbits by the oral route. In rats dosed on days 6-15 of gestation with 100, 500 or 1000 mg/kg/day of caprolactam, the maternal survival rate was significantly lower in the high-dose group and implantation efficiencies were slightly lower in the 100 and 1000 mg/groups (but not the 500 mg/kg) than in the control. The incidence of fetal death was comparable for all groups, and the incidence of fetal viability was considerably lower in the high-dose group (but not the mid or low) than in the control group. Visceral anomalies and one visceral variant were observed in one 100 mg/kg and one 500 mg/kg pup, respectively. The anomalies included exencephaly, an incomplete left eyelid, microphthalmia (right), and a protruding tongue. No skeletal anomalies were observed. It was concluded that caprolactam at levels up to at least 500 mg/kg of body weight produced no teratogenic effects in the Fischer 344 rats. In rabbits receiving 50, 150 or 250 mg/kg caprolactam on days 6-28 of gestation, the pregnancy rate in all groups was at least 80%. The numbers of corpora lutea, live and dead fetuses, resorptions, the sex ratio and the pre- and post-implantation losses were not significantly different among the test and control groups. The incidence of major malformations and of minor skeletal anomalies was unaffected by treatment with caprolactam. Maternal weights were depressed in the group receiving 250 mg/kg. Treatment of a separate group with a positive control substance (6-aminonicotinamide) resulted in significantly (P less than 0.001) increased incidences of major malformations, minor visceral anomalies and minor skeletal anomalies. Maternal toxicity in terms of mortality was observed in pregnant rabbits treated with caprolactam at a dose of 250 mg/kg/day. Fetotoxicity was evidenced by lower fetal weights at the 150 and 250 mg/kg/day levels, and an increased incidence of thirteenth ribs was observed at the 250 mg/kg/day dose level. Neither embryotoxicity nor teratogenicity occurred at any dose level.
authors: Department of Toxicology, Allied Corporation, Morristown, NJ.
authors: S C
authors: SC
authors: Gad
authors: K
authors: K
authors: Robinson
authors: D G
authors: DG
authors: Serota
authors: B R
authors: BR
authors: Colpean
mesh_terms: D000818:Animals; D001381:Azepines / Q000633:toxicity*; D001835:Body Weight / Q000187:drug effects; D002209:Caprolactam / Q000633:toxicity*; D004435:Eating / Q000187:drug effects; D005260:Female; D005865:Gestational Age; D008297:Male; D011247:Pregnancy; D011817:Rabbits; D051381:Rats; D013045:Species Specificity; D013723:Teratogens
chemical_list: D001381:Azepines; D013723:Teratogens; D002209:Caprolactam